Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AceiMR
NCT00113698Phase 3Terminated
- Sponsor
- University of Utah
- Start
- Dec 2004
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in mitral regurgitation (MR) comparing Placebo with Enalapril (2 arms). Primary endpoint: Left Ventricular Size at 6 months. Started Dec 2004; status: terminated.
02
Drugs
enalapril
03
Conditions
mitral regurgitation (MR)
Beyond the preview
Go deeper on NCT00113698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00113698.